LivaNova

By MobiHealthNews 03:55 pm March 3, 2020
Fitbit and Belgium-based FibriCheck have extended their partnership to bring the latter’s atrial fibrillation detection app to four new countries in the EU: France, Germany, Italy and Spain. It was previously made available to Fitbit smartwatch users in the UK, Ireland, the Netherlands and Belgium back in September 2019. “For more than a decade, Fitbit has helped millions of people around the...
By Dave Muoio 02:57 pm January 2, 2020
On Apple and patents. A New York University School of Medicine cardiologist is unhappy with Apple Watch’s heart rate irregularity detection feature, which he claims in a new lawsuit infringes his own patent for atrial fibrillation detection technology. Filed in the US District Court for the Eastern District of New York on December 27, 2019, the suit describes Dr. Joseph Wiesel’s invention and his...
By Dave Muoio 04:35 pm October 17, 2017
Weight loss headset a crowdfunding hit. Brain-stimulating weight loss headset Modius has raised more than $1.5 million in its first Indiegogo campaign, beating its funding goal by more than 3,000 percent. Developed by Belfast- and San Diego-based Neurovalens, the wearable device aims to activate a nerve in the brain that controls appetite and, subsequently, body weight. Neurovalens plans to use...
By Dave Muoio 12:43 pm October 10, 2017
London-based medical device manufacturer LivaNova has announced FDA approval of its most recent Vagus Nerve Stimulation Therapy (VNS Therapy) System, which will be the smallest and lightest responsive therapy available for drug-resistant epilepsy patients aged four years and older. The treatment consists of the new SenTiva implantable generator, the VNS Therapy Programming System, a wireless wand...